Outcome of AGM
Outcome of 28th Annual General Meeting (AGM) held on 14th August, 2017 and Voting Results14-08-2017
14-08-2017
Analyst / Investor Meet Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Wednesday, August 16, 2017 at 11:00 a.m. IST to discuss the Un-audited Financial Results for the Q1 Financial Year 2018, to be declared on 14th August, 2017.11-08-2017
Closure of Trading Window
With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Board Meeting of our Company will be held on Monday, the 14th August, 2017 at 3.30 p.m. at the Registered Office, SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad 500034 of the Company, to consider, inter alia, and take on record the following...05-08-2017
Press Release
With reference to above subject, please find enclosed Press Release of our company titled 'Suven Life Sciences secures a Product Patent in Australia'21-07-2017
Shareholding for the Period Ended June 30, 2017
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here18-07-2017
Statement Of Investor Complaints For The Quarter Ended 30Th June, 2017
Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the statement of Investor complaints/grievances, for the quarter ended 30th June, 2017.17-07-2017
Press Release
Please find enclosed Press Release of our company titled 'Suven at Alzheimer's Association International Conference (AAIC) in London'14-07-2017
Suven Life gets NCEs' patents from Israel, Macau, S Korea
Suven Life Sciences has received product patents from Israel, Macau and South Korea for New Chemical Entities (NCEs) used in the treatment of disorders associated with neurodegenerative diseases.10-07-2017
Press Release
Please find enclosed Press Release of our company titled 'Suven Life Sciences secures Product Patents in Israel, Macau and South Korea'.10-07-2017
Suven Life gets patents for molecule to be used in treatment of neuro-degenerative disease
Drug firm Suven Life Sciences has received one product patent each from Australia and the US for its molecule to be used in the treatment of neuro-degenerative diseases. These patents are valid...13-06-2017